| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8662813 | International Journal of Cardiology | 2017 | 5 Pages |
Abstract
Levels of fibrinogen >Â 240Â mg/dL compensate the decrease in clot firmness observed in thrombocytopenic patients following CPB, and reduce bleeding and transfusion needs.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Marco Ranucci, Ekaterina Baryshnikova, Matteo Ranucci, Simona Silvetti, Surgical and Clinical Outcome Research (SCORE) Group Surgical and Clinical Outcome Research (SCORE) Group,